GOSS logo

Gossamer Bio (GOSS)

Profile

Full Name

Gossamer Bio, Inc.

Ticker Symbol

GOSS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 8, 2019

Indexes

Not included

Website

http://www.gossamerbio.com

Employees

144

Key Details

Price

$0.81(-1.45%)

Market cap

$184.73M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$114.70M

Annual EPS

-$0.25(+78.81% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.81
GOSS price is $0.81

30-Day Relative Volume

0.51
GOSS 30-day relative volume is 0.51

Price Performance

Price Most recent change

-1.45%
GOSS price was down -1.45% on Apr 14, 2025

Price YTD change

-10.17%
GOSS price is down -10.17% since January 1st

Price 1-year change

-5.24%
GOSS price is down -5.24% year-on-year

Price 3-year change

-90.81%
GOSS price is down -90.81% over the past 3 years

Price Range

Price All-time high

$27.15
GOSS price is currently -97.01% below its historical high of $27.15

Price 3-year low

$0.45
GOSS price is currently +79.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$184.73M
GOSS market capitalization is $184.73 million

Market cap 3-year change

-72.73%
GOSS market capitalization is down -72.73% over the past 3 years

Market cap All-time high

$1.63B
GOSS market capitalization is currently -88.69% below its historical high of $1.63 billion

Market cap sector rank

56.17%
GOSS market capitalization is higher than 56.17% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.44%
GOSS shares outstanding is up +0.44% year-on-year

Shares Outstanding 3-Year Change

+196.81%
GOSS shares outstanding is up +196.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.37
GOSS beta is 1.37

200-day SMA

$0.98
GOSS price is currently -17.14% below its 200-day simple moving average

50-day SMA

$1.18
GOSS price is currently -30.82% below its 50-day simple moving average

RSI

34.85
GOSS 14-day relative strength index is 34.85

Volume

0.51
GOSS 30-day relative volume is 0.51

ATR

$0.11
GOSS average true range is $0.11

10-day Historical Volatility

130.20%
GOSS 10-day historical volatility is 130.20%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$114.70M
GOSS annual revenue is $114.70 million

Revenue Analysts estimate

$19.85M
GOSS annual revenue is currently +477.78% higher than the consensus analysts' forecast

Revenue 1-year change

-
GOSS annual revenue 1-year change is unknown

Revenue Sector rank

57.56%
GOSS annual revenue is higher than 57.56% of companies in Healthcare sector

EPS

EPS

-$0.25
GOSS annual earnings per share is -$0.25

EPS Analysts estimate

-$0.73
GOSS annual earnings per share is currently -65.91% lower than the consensus analysts' forecast

EPS 1-year change

+78.81%
GOSS annual earnings per share is up +78.81% year-on-year

EPS Sector rank

76.34%
GOSS annual earnings per share is higher than 76.34% of companies in Healthcare sector

Profit

Gross profit

-
GOSS annual gross profit value is unknown

Gross margin

-
GOSS annual gross profit margin value is unknown

Operating profit

-$59.92M
GOSS annual operating income is -$59.92 million

Operating margin

-52.24%
GOSS annual operating profit margin is -52.24%

Net income

-$56.53M
GOSS annual net profit is -$56.53 million

Net margin

-49.28%
GOSS annual net profit margin is -49.28%

Expenses

Total expenses

$174.62M
GOSS annual total expenses is $174.62 million

Operating expenses

$174.62M
GOSS annual total operating expenses is $174.62 million

Cost of goods sold

-
GOSS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$36.13M
GOSS annual SGA is $36.13 million

Depreciation and amortization

$4.15M
GOSS annual depreciation & amortization is $4.15 million

Interest expense

$11.52M
GOSS annual interest expense is $11.52 million

Income tax

$893.00K
GOSS annual income tax is $893.00 thousand

EBIT & EBITDA

EBIT

-$44.12M
GOSS annual earnings before interest & taxes is -$44.12 million

EBITDA

-$39.97M
GOSS annual EBITDA is -$39.97 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$315.29M
GOSS annual total assets is $315.29 million

Non current assets

$5.40M
GOSS annual long term assets is $5.40 million

Current assets

$309.89M
GOSS annual total current assets is $309.89 million

Cash and cash equivalents

$46.07M
GOSS annual cash & cash equivalents is $46.07 million

Accounts receivable

-
GOSS annual accounts receivable value is unknown

Inventory

-
GOSS annual inventory value is unknown

Liabilities

Total liabilities

$285.80M
GOSS annual total liabilities is $285.80 million

Long term liabilities

$240.79M
GOSS annual total long term liabilities is $240.79 million

Current liabilities

$45.01M
GOSS annual total current liabilities is $45.01 million

Accounts payable

$2.32M
GOSS annual accounts payable is $2.32 million

Debt

Total debt

$202.88M
GOSS annual total debt is $202.88 million

Total debt 1-year change

-4.51%
GOSS annual total debt is down -4.51% year-on-year

Long term debt

$201.92M
GOSS annual long term debt is $201.92 million

Short term debt

$961.00K
GOSS annual short term debt is $961.00 thousand

Equity & Capital

Shareholders equity

$29.49M
GOSS annual stockholders equity is $29.49 million

Book value

$29.49M
GOSS annual book value is $29.49 million

Retained earnings

-$1.27B
GOSS annual retained earnings is -$1.27 billion

Working capital

$264.88M
GOSS annual working capital is $264.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$3.47M
GOSS annual cash flow from operations is -$3.47 million

Cash from operations 1-year change

+97.82%
GOSS annual cash flow from operations is up +97.82% year-on-year

Cash from investing

$29.02M
GOSS annual cash flow from investing activities is $29.02 million

Cash from investing 1-year change

+126.15%
GOSS annual cash flow from investing activities is up +126.15% year-on-year

Cash from financing

-$11.49M
GOSS annual cash flow from financing activities is -$11.49 million

Cash from financing 1-year change

-106.04%
GOSS annual cash flow from financing activities is down -106.04% year-on-year

CAPEX

CAPEX

-
GOSS annual capital expenditures value is unknown

CAPEX 1-year change

-
GOSS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$3.47M
GOSS annual free cash flow is -$3.47 million

Free cash flow 1-year change

+97.82%
GOSS annual free cash flow is up +97.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GOSS annual gross profit margin value is unknown

Operating margin

-52.24%
GOSS annual operating profit margin is -52.24%

Net margin

-49.28%
GOSS annual net profit margin is -49.28%

ROA & ROE

ROA

-17.93%
GOSS annual return on assets is -17.93%

ROE

-122.54%
GOSS annual return on equity is -122.54%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GOSS price to earnings ratio value is unknown

PE ratio Sector rank

-
GOSS price to earnings ratio is unknown

PB Ratio

PB ratio

6.26
GOSS price to book ratio is 6.26

PB ratio Sector rank

86.58%
GOSS price to book ratio is higher than 86.58% of companies in Healthcare sector

PS Ratio

PS ratio

1.61
GOSS price to sales ratio is 1.61

PS ratio Sector rank

37.82%
GOSS price to sales ratio is higher than 37.82% of companies in Healthcare sector

Enterprise value

Enterprise value

$341.54M
GOSS enterprise value is $341.54 million

Enterprise value Sector rank

64.71%
GOSS enterprise value is higher than 64.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.55
GOSS EV/EBITDA is -8.55

EV/EBITDA Sector rank

12.35%
GOSS EV/EBITDA is higher than 12.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.88
GOSS annual current ratio is 6.88

Quick ratio

-
GOSS annual quick ratio value is unknown

Leverage

Debt to equity

6.70
GOSS annual debt to equity ratio is 6.70

Interest coverage ratio

-3.83
GOSS annual interest coverage ratio is -3.83

Risk & Stability

Piotroski F-Score

-
GOSS piotroski f-score value is unknown

Altman Z-Score

-4.33
GOSS altman z-score is -4.33

Analyst ratings

Recent major analysts updates

Mar 14, 25 Wedbush
Outperform
Jan 30, 25 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Sep 17, 24 HC Wainwright & Co.
Buy
Aug 30, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Wedbush
Outperform
Jun 25, 24 Oppenheimer
Outperform
Jun 17, 24 Goldman Sachs
Buy
May 20, 24 HC Wainwright & Co.
Buy
May 8, 24 Wedbush
Outperform

Institutional Ownership

Similar stocks

DSGN logo
Design Therapeutics (DSGN)
CRDF logo
Cardiff Oncology (CRDF)
TuHURA Biosciences (HURA)
MDWD logo
MediWound (MDWD)
DRTS logo
Alpha Tau Medical (DRTS)
Performant Healthcare (PHLT)
CDXS logo
Codexis (CDXS)
ELDN logo
Eledon Pharmaceuticals (ELDN)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
  • What is the ticker symbol for Gossamer Bio?
  • Does Gossamer Bio pay dividends?
  • What sector is Gossamer Bio in?
  • What industry is Gossamer Bio in?
  • What country is Gossamer Bio based in?
  • When did Gossamer Bio go public?
  • Is Gossamer Bio in the S&P 500?
  • Is Gossamer Bio in the NASDAQ 100?
  • Is Gossamer Bio in the Dow Jones?
  • When was Gossamer Bio's last earnings report?
  • When does Gossamer Bio report earnings?
  • Should I buy Gossamer Bio stock now?

What is the ticker symbol for Gossamer Bio?

The ticker symbol for Gossamer Bio is NASDAQ:GOSS

Does Gossamer Bio pay dividends?

No, Gossamer Bio does not pay dividends

What sector is Gossamer Bio in?

Gossamer Bio is in the Healthcare sector

What industry is Gossamer Bio in?

Gossamer Bio is in the Biotechnology industry

What country is Gossamer Bio based in?

Gossamer Bio is headquartered in United States

When did Gossamer Bio go public?

Gossamer Bio's initial public offering (IPO) was on February 8, 2019

Is Gossamer Bio in the S&P 500?

No, Gossamer Bio is not included in the S&P 500 index

Is Gossamer Bio in the NASDAQ 100?

No, Gossamer Bio is not included in the NASDAQ 100 index

Is Gossamer Bio in the Dow Jones?

No, Gossamer Bio is not included in the Dow Jones index

When was Gossamer Bio's last earnings report?

Gossamer Bio's most recent earnings report was on Mar 13, 2025

When does Gossamer Bio report earnings?

The next expected earnings date for Gossamer Bio is May 7, 2025

Should I buy Gossamer Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page